Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Soy products in the management of breast cancer.

Magee PJ, Rowland I.

Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):586-91. doi: 10.1097/MCO.0b013e328359156f. Review.

PMID:
23075937
2.

Soy isoflavones, CYP1A1, CYP1B1, and COMT polymorphisms, and breast cancer: a case-control study in southwestern China.

Wang Q, Li H, Tao P, Wang YP, Yuan P, Yang CX, Li JY, Yang F, Lee H, Huang Y.

DNA Cell Biol. 2011 Aug;30(8):585-95. doi: 10.1089/dna.2010.1195. Epub 2011 Mar 27.

PMID:
21438753
3.

Combined effects of MDM2 SNP309 and TP53 R72P polymorphisms, and soy isoflavones on breast cancer risk among Chinese women in Singapore.

Koh WP, Van Den Berg D, Jin A, Wang R, Yuan JM, Yu MC.

Breast Cancer Res Treat. 2011 Dec;130(3):1011-9. doi: 10.1007/s10549-011-1680-2. Epub 2011 Jul 21.

4.

Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies.

Dong JY, Qin LQ.

Breast Cancer Res Treat. 2011 Jan;125(2):315-23. doi: 10.1007/s10549-010-1270-8. Epub 2010 Nov 27. Review.

PMID:
21113655
5.

Soy isoflavones and risk of cancer recurrence in a cohort of breast cancer survivors: the Life After Cancer Epidemiology study.

Guha N, Kwan ML, Quesenberry CP Jr, Weltzien EK, Castillo AL, Caan BJ.

Breast Cancer Res Treat. 2009 Nov;118(2):395-405. doi: 10.1007/s10549-009-0321-5. Epub 2009 Feb 17.

6.

Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy.

Kang X, Zhang Q, Wang S, Huang X, Jin S.

CMAJ. 2010 Nov 23;182(17):1857-62. doi: 10.1503/cmaj.091298. Epub 2010 Oct 18.

7.

Differential influence of dietary soy intake on the risk of breast cancer recurrence related to HER2 status.

Woo HD, Park KS, Ro J, Kim J.

Nutr Cancer. 2012;64(2):198-205. doi: 10.1080/01635581.2012.635261. Epub 2012 Jan 2.

PMID:
22211813
8.
9.

Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.

Messina M, McCaskill-Stevens W, Lampe JW.

J Natl Cancer Inst. 2006 Sep 20;98(18):1275-84. Review.

10.

Perspectives on the soy-breast cancer relation.

Messina M, Wu AH.

Am J Clin Nutr. 2009 May;89(5):1673S-1679S. doi: 10.3945/ajcn.2009.26736V. Epub 2009 Apr 1.

11.

Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.

Messina MJ, Wood CE.

Nutr J. 2008 Jun 3;7:17. doi: 10.1186/1475-2891-7-17. Review.

12.

Soy for breast cancer survivors: a critical review of the literature.

Messina MJ, Loprinzi CL.

J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. Review.

13.

Prevalence, sources, and predictors of soy consumption in breast cancer.

Lammersfeld CA, King J, Walker S, Vashi PG, Grutsch JF, Lis CG, Gupta D.

Nutr J. 2009 Jan 22;8:2. doi: 10.1186/1475-2891-8-2.

14.

Soy and its isoflavones: the truth behind the science in breast cancer.

Douglas CC, Johnson SA, Arjmandi BH.

Anticancer Agents Med Chem. 2013 Oct;13(8):1178-87. Review.

PMID:
23919747
15.

Soy, red clover, and isoflavones and breast cancer: a systematic review.

Fritz H, Seely D, Flower G, Skidmore B, Fernandes R, Vadeboncoeur S, Kennedy D, Cooley K, Wong R, Sagar S, Sabri E, Fergusson D.

PLoS One. 2013 Nov 28;8(11):e81968. doi: 10.1371/journal.pone.0081968. eCollection 2013. Review.

16.

Epidemiology of soy exposures and breast cancer risk.

Wu AH, Yu MC, Tseng CC, Pike MC.

Br J Cancer. 2008 Jan 15;98(1):9-14. doi: 10.1038/sj.bjc.6604145. Epub 2008 Jan 8. Review.

17.

Is soy consumption good or bad for the breast?

Hilakivi-Clarke L, Andrade JE, Helferich W.

J Nutr. 2010 Dec;140(12):2326S-2334S. doi: 10.3945/jn.110.124230. Epub 2010 Oct 27. Review.

18.

[Soy isoflavones and human health: breast cancer and puberty timing].

Valladares L, Garrido A, Sierralta W.

Rev Med Chil. 2012 Apr;140(4):512-6. doi: 10.4067/S0034-98872012000400014. Review. Spanish.

19.
20.

Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer.

Messina M, Hilakivi-Clarke L.

Nutr Cancer. 2009;61(6):792-8. doi: 10.1080/01635580903285015.

PMID:
20155618
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk